Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedStar Washington Cancer Institute is a premier multidisciplinary cancer center located in Washington, D.C., and serves as the flagship oncology program for MedStar Health. As the largest cancer provider in the nation's capital, the institute offers a comprehensive range of services including advanced surgical oncology, medical oncology, and radiation therapy. It is a key component of the MedStar Georgetown Cancer Institute, facilitating patient access to cutting-edge research and clinical trials through its partnership with the NCI-designated Georgetown Lombardi Comprehensive Cancer Center. The facility is known for its specialized centers of excellence in breast, gastrointestinal, and thoracic cancers, among others. With a focus on personalized medicine and holistic support, the institute provides genetic counseling, nutritional support, and survivorship programs to its diverse patient population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Washington Cancer Institute.